Gb-Liverpool: Glp Toxicology Evaluation Of Long-Acting Injectable (Lai) Products For Ltbi Prevention And Hcv Cure

  Address - United Kingdom

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 79076169

  Document Type - Tender Notices

Description - The University of Liverpool, through its LONGEVITY project funded by Unitaid, is implementing product development and commercialization of Long-Acting Injectable (LAI) formulations for malaria and tuberculosis prevention, and a hepatitis C virus cure for Low- and Middle-Income Countries (LMIC's). The University of Liverpool was awarded 32 million US dollars in early 2020 from Unitaid (https://unitaid.org/) as part of the 40 million US dollar project to fund these activities to commercialisation.https://unitaid.org/news-blog/unitaid-invests-in-long-acting-medicines-to-simplify-treatment-and-prevention-for-hiv-tb-malaria-and-hcv/#enhttps://www.liverpool.ac.uk/chemistry/news/articles/24m-boost-

Gt Ref Id - 79076169

Deadline - Apr 01, 2024